ArticleOpen medicine (Warsaw, Poland)2026
Effects of EECP combined with individualized cardiac exercise rehabilitation on lipoprotein(a) levels in patients with coronary heart disease.
Article in Open medicine (Warsaw, Poland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to evaluate the effects of combining enhanced external counterpulsation (EECP) with individualized cardiac exercise rehabilitation training on lipoprotein(a) levels in patients with coronary heart disease (CHD). Methods: This retrospective analysis included 122 patients with CHD who received treatment at the hospital between January 2023 and September 2023. 61 patients were assigned to the study group, receiving EECP therapy plus individualized cardiac exercise rehabilitation, while another 61 in the control group were given standard mattress therapy combined with the same exercise rehabilitation. Therapeutic efficacy was evaluated over a 6-month period and compared between groups. In addition, changes in blood lipid parameters were assessed before treatment and 30 days after treatment. Results: After treatment, no statistically significant changes were observed in total cholesterol, triglycerides, high-density lipoprotein cholesterol, or very-low-density lipoprotein cholesterol (p>0.05). In contrast, low-density lipoprotein cholesterol and lipoprotein(a) levels decreased compared with pretreatment values. During follow-up, the total effective treatment rate in the study group reached 93.83 % at 6 months. Conclusions: The combination of EECP and individualized cardiac exercise rehabilitation training was associated with a reduction in lipoprotein(a) levels and improved overall cardiovascular status in patients with CHD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.